Related Experiment Videos
New therapeutic avenues in autoimmunity
H Amital1, M Swissa, Y Bar-Dayan
1Department of Medicine B, Sheba Medical Center, Tel-Hashomer, Israel.
Research in Immunology
|July 1, 1996
Summary
Recent advances enhance understanding of autoimmunity development, focusing on cellular interactions and cytokine roles. New therapeutic strategies, including monoclonal antibodies and expanded uses of intravenous immunoglobulin therapy (IVIG), offer improved treatment outcomes.
Area of Science:
- Immunology
- Autoimmune Diseases
- Therapeutics
Background:
- Significant progress in understanding autoimmunity pathogenesis over the last decade.
- Key roles of cellular interactions, cytokines, and adhesion molecules in autoimmune conditions.
- Development of monoclonal antibodies to modulate autoimmune processes.
Purpose of the Study:
- To review recent therapeutic modalities for autoimmune diseases.
- To discuss new data on established treatments like IVIG.
- To provide an updated perspective on managing autoimmunity.
Main Methods:
- Literature review of therapeutic advancements since the previous report.
- Analysis of new data on existing treatments, including IVIG.
- Synthesis of information on novel therapeutic strategies.
Main Results:
- Expanded understanding of autoimmune disease mechanisms.
- Identification of new indications and applications for IVIG.
- Emergence of novel therapeutic agents targeting cellular interactions.
Conclusions:
- Therapeutic landscape for autoimmunity has evolved significantly.
- Monoclonal antibodies and IVIG represent key advancements.
- Continued research promises further improvements in autoimmune disease management.